KU hospital authority sues CVS over $62 million drug savings

A federal lawsuit filed by the University of Kansas Hospital Authority says CVS and its subsidiaries diverted nearly $62 million in prescription drug savings that should have supported care at the KU health system.

The complaint says the money came from the federal 340B drug discount program, a 1992 law designed to help hospitals and clinics that treat large numbers of low-income and otherwise vulnerable patients buy outpatient drugs at lower cost. In Kansas, the hospital authority says it contracted with CVS Health Corporation and CaremarkPCS Health to process 340B claims and fill prescriptions, but that CVS kept the savings between 2020 and 2025 instead of passing them through as expected.

At stake is more than a billing dispute. For the University of Kansas Health System, which serves Lawrence, Douglas County and patients across Kansas, the alleged loss could affect staffing, care delivery and the money available for reinvestment into services that often operate on thin margins. Hospital and advocacy groups say 340B savings are commonly used for uncompensated care, free or low-cost drugs, vaccines, mental health services and other community health work, which means the dollars in dispute can shape access far beyond the pharmacy counter.

The lawsuit says the conflict escalated after the hospital asked CVS for an audit and CVS terminated the contract. The hospital authority’s allegation puts a basic accountability question at the center of the case: did a major pharmacy middleman divert savings that were meant to lower costs and expand care locally?

The Kansas case is part of a larger set of suits filed in federal court in Kansas, Michigan and New York by hospitals represented by the law firm Frier Levitt. Together, those cases seek about $250 million. CVS has said it does not comment on matters subject to ongoing litigation.

The case also lands in the middle of a national fight over how the 340B program should work when contract pharmacies are involved. Health Resources and Services Administration guidance says covered entities should identify pharmacy locations and covered entity locations in written contracts and register those arrangements. As the KU hospital authority presses its claim, the outcome could influence how prescription savings are handled across the region and how much of that money reaches patients instead of disappearing into corporate pharmacy finance.